All Type of News
Will ‘Descovy’ change paradigm in HIH treatment?
‘Gilead,’ an international biopharmaceutical company, is currently working hard.
It has decided to launch ‘Descovy(generic name: emtricitabine/tenofovir alafenamide),’ the first HIV backbone treatment containing a TA...
Who are candidates for Moon administration’s first Minister of Health and Welfare?
It was told there was a high chance for the Jae-In Moon administration’s first Minister of Health and Welfare to be Rep. Yong-Ik Kim, a director of democracy research at The Minjoo Party.
Since President Moon promise...
JW Holdings signs supply agreement of ‘ertapenem’ ingredients with Indian Grand Pharma
JW Holdings will enter advanced markets, such as the U.S. Canada, through exports of ‘ertapenem’ ingredients, a next-generation antibiotic.
The company announced on the 24th that it signed an agreement to supply ‘ert...
Yuhan Corporation ‘certain’ to generate 2 medicines of KRW 100 billion salesYuhan Corporation, the top sales company in the pharmaceutical industry, is certain to generate 2 super blockbuster medicines with more than KRW 100 billion annual sales.
Accor...
|
It is necessary to develop evaluations based on medical records
A policy debate for the National Health Insurance was held at the National Assembly to improve quality of medical services in Korea, and a shift of paradigm for its deliberation and evaluation system.
Sponsored by th...
Last year’s medical device manufacturing performance was KRW 5.6025 trillion, increased by 12%
The last year’s manufacturing performance of medical devices was KRW 5.6025 trillion increased by 12% compared to 2015. A type of medical device that was manufactured the most was dental implant with KRW 840.7 billion...
Large-scale international event proposing Korean pharma industry’s growth roadmap
Jointly hosted by UBM, a global events organizer, and the Korea Pharmaceutical Traders Association(KPTA) and sponsored by the Ministry of Food and Drug Safety, Chungbuk Technopark, the Korea Federation of SMEs, the Ko...
Will ‘Vemlidy’ become a new power in chronic hepatitis B treatment market?
Pharmaceutical companies have been highly competitive to develop new chronic hepatitis B treatments. In the competition, Gilead developed a new drug called ‘Vemlidy(generic name: tenofovir alafenamide, aka. TAF)’ and ...
More pharma sales reps having multiple jobs
It seems there are more sales representatives having multiple jobs at pharmaceutical companies.
While having sales activities for products of the company they belong, these representatives are making extra earnings b...
‘Standard of Aggregation Label’ proposed
‘Standard of Aggregation Label’ was revealed before enforcement of the serial number reporting system on pharmaceutical wholesalers from the coming 1st of July.
After going through expert meetings with people concern...
